<DOC>
	<DOCNO>NCT01318473</DOCNO>
	<brief_summary>This prospective , single-arm , single-center , open-label study evaluate use ActiSight™ Needle Guidance System patient lung lesion small 15 mm undergo CT-guided percutaneous chest aspiration . Target location chest area ; procedure perform trained physician .</brief_summary>
	<brief_title>The Use ActiSight™ Needle Guidance System Patients Undergoing CT-Guided With Lesions Smaller Than 15 mm</brief_title>
	<detailed_description>Subjects schedule clinically indicate percutaneous chest aspiration/biopsy procedure screen inclusion study . Within 18-day screening period , eligible subject enrol study undergo percutaneous chest aspiration percutaneous biopsy utilize ActiSight™ Needle Guidance system use CT guide needle . Subjects followed-up least one hour clinic safety preliminary accuracy evaluation . An erect chest radiograph perform within 90 minute observation chest aspiration detect majority post procedure pneumothoraces . A follow-up visit conduct within 7-10 day procedure day safety evaluation .</detailed_description>
	<criteria>Male female subject , 18 year age old time enrollment Subjects schedule clinically indicate percutaneous chest aspiration/biopsy procedure Subjects lung lesion less 15 mm . Written inform consent participate study Ability comply requirement study procedure Subjects tolerate mild sedation Subjects participate active stage drug , intervention treatment trial within 30 day enrollment . Subjects preexist condition , opinion investigator , interfere conduct study . Subjects uncooperative follow instruction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>cancer</keyword>
</DOC>